Compound information
- Natural Products
- ZC565603
- Molecular Formula
- C15H22N2O5S
- Molecular Weight
- 342.124942804 g/mol
- Structure
-
- IUPAC Name
- ethyl 4-(4-ethoxyphenyl)sulfonylpiperazine-1-carboxylate
- InChI
- InChI=1S/C15H22N2O5S/c1-3-21-13-5-7-14(8-6-13)23(19,20)17-11-9-16(10-12-17)15(18)22-4-2/h5-8H,3-4,9-12H2,1-2H3
- InChI Key
- GUVOARYYPAWPHZ-UHFFFAOYSA-N
- SMILES
- CCOC(=O)N1CCN(S(=O)(=O)c2ccc(OCC)cc2)CC1
- Source
- ZINC000000617033
Warheads
- Carbamate
-
ADMET Property
Physicochemical Property
Property | Value | Property | Value |
---|---|---|---|
Heavy Atom Count | 23 | Ring Count | 2 |
Heteroatom Count | 8 | Rotatable Bond Count | 5 |
Hydrogen Bond Acceptor Count | 5 | Hydrogen Bond Donor Count | 0 |
Topological Polar Surface Area | 76.15 Å2 | LogP | 2.138 |
LogS | -3.332 | LogD | 2.777 |
Absorption
Property | Value | Property | Value |
---|---|---|---|
Pgp inhibitor | 0.046 | Pgp substrate | 0.023 |
HIA | 0.976 | F20 % | 0.979 |
F30 % | 0.822 | Caco-2 | -4.327 |
MDCK | -4.778 |
Distribution
Property | Value | Property | Value |
---|---|---|---|
BBB Penetration | 0.658 | PPB | 69.738 |
VD | 1.521 | Fu | 0.748 |
Metabolism
Property | Value | Property | Value |
---|---|---|---|
CYP1A2 inhibitor | 0.121 | CYP1A2 substrate | 0.528 |
CYP2A6 substrate | 0.753 | CYP2B6 substrate | 0.721 |
CYP2C19 inhibitor | 0.627 | CYP2C19 substrate | 0.831 |
CYP2C8 substrate | 0.613 | CYP2C9 inhibitor | 0.7 |
CYP2C9 substrate | 1.0 | CYP2D6 inhibitor | 0.011 |
CYP2D6 substrate | 0.665 | CYP2E1 substrate | 0.63 |
CYP3A4 inhibitor | 0.056 | CYP3A4 substrate | 1.0 |
Excretion
Property | Value | Property | Value |
---|---|---|---|
T1/2 | 0.422 | CL | 5.304 |
Toxicity
Property | Value | Property | Value |
---|---|---|---|
hERG Blockers | 0.422 | Hepatotoxicity | 0.608 |
Mutagenicity | 0.122 | Rat Oral Acute Toxicity | 0.296 |
FDAMDD | 0.056 | Skin Sensitization | 0.0 |
Carcinogenicity | 0.496 | Eye Corrosion | 0.002 |
Eye Irritation | 0.011 | Respiratory Toxicity | 0.11 |
Environmental Toxicity
Property | Value | Property | Value |
---|---|---|---|
Bioconcentration Factors | 0.54 | IGC50 | 3.064 |
LC50FM | 2.663 | LC50DM | 0.384 |
Tox21 Pathway
Property | Value | Property | Value |
---|---|---|---|
NR-AR | 0.323 | NR-AR-LBD | 0.367 |
NR-AhR | 0.076 | NR-Aromatase | 0.092 |
NR-ER | 0.35 | NR-ER-LBD | 0.406 |
NR-PPAR-gamma | 0.132 | SR-ARE | 0.592 |
SR-ATAD5 | 0.305 | SR-HSE | 0.081 |
SR-MMP | 0.018 | SR-p53 | 0.03 |
Similar covalent inhibitors
Similar covalent drugs
No similar covalent drugs found for this compound.